- Home
- ILMN vs CLS Comparison
ILMN vs CLS Comparison
Compare ILMN & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- CLS
- Stock Information
- Founded
- ILMN 1998
- CLS 1994
- Country
- ILMN United States
- CLS Canada
- Employees
- ILMN N/A
- CLS N/A
- Industry
- ILMN Medical Specialities
- CLS Electrical Products
- Sector
- ILMN Health Care
- CLS Technology
- Exchange
- ILMN Nasdaq
- CLS Nasdaq
- Market Cap
- ILMN 15.9B
- CLS 15.1B
- IPO Year
- ILMN 2000
- CLS 1998
- Fundamental
- Price
- ILMN $94.20
- CLS $119.27
- Analyst Decision
- ILMN Buy
- CLS Strong Buy
- Analyst Count
- ILMN 18
- CLS 9
- Target Price
- ILMN $158.11
- CLS $102.22
- AVG Volume (30 Days)
- ILMN 3.1M
- CLS 6.2M
- Earning Date
- ILMN 02-06-2025
- CLS 01-29-2025
- Dividend Yield
- ILMN N/A
- CLS N/A
- EPS Growth
- ILMN N/A
- CLS 77.83
- EPS
- ILMN N/A
- CLS 3.61
- Revenue
- ILMN $4,372,000,000.00
- CLS $9,646,000,000.00
- Revenue This Year
- ILMN $2.36
- CLS $10.43
- Revenue Next Year
- ILMN $6.64
- CLS $13.51
- P/E Ratio
- ILMN N/A
- CLS $33.92
- Revenue Growth
- ILMN N/A
- CLS 21.17
- 52 Week Low
- ILMN $93.50
- CLS $40.02
- 52 Week High
- ILMN $156.66
- CLS $144.27
- Technical
- Relative Strength Index (RSI)
- ILMN 21.89
- CLS 49.09
- Support Level
- ILMN $99.33
- CLS $123.81
- Resistance Level
- ILMN $105.67
- CLS $137.89
- Average True Range (ATR)
- ILMN 4.94
- CLS 9.81
- MACD
- ILMN -1.77
- CLS -1.55
- Stochastic Oscillator
- ILMN 1.80
- CLS 29.12
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.